Eli Lilly and Company (LLY)

Financial Performance

Eli Lilly and Company's financial performance has been strong, with a steady increase in revenue, gross profit, and operating income. The company's revenue grew by 22.3% year over year to $11.4B, while the gross profit increased by 20.5% to $9.3B. Operating income also saw significant growth of 44.1% year over year to reach $4.4B, indicating efficient operations and cost management.

The EBITDA ratio was at a healthy level of 0.2 last quarter which indicates good profitability.

Stock Price

The stock price is currently down -18.3% at $746.2 from the last month which might be concerning for some investors but it needs to be taken into consideration that the stock's 200-day moving average is still higher at $834.56 suggesting potential undervaluation at current levels.

The RSI value stands at a lowly 23.44 indicating oversold conditions and potentially an attractive entry point for investors looking for rebound opportunities.

Alternative Data Signals

Web traffic has increased significantly by 153.6% YoY which indicates growing interest in the company or its products/services among internet users.

The number of job openings remains stable, implying no major changes in their employment strategy or business outlook.

A high percentage (83%) of employees report positive business outlook which can serve as an internal vote of confidence about future prospects of Eli Lilly and Company.

Social media presence shows positive growth across all platforms (Twitter up by 0.9%, Instagram up by29 .7%, Facebook up by2 .7%), showing an increasing ability to engage with the public and potential customers.

Conclusion

Despite a recent dip in stock price, Eli Lilly's strong financial performance, positive alternative data signals, and oversold technical indicators suggest that the stock has potential for rebound. Therefore, the AI analysis is cautiously bullish.

Note: This AI Stock Analysis is based on data as of November 16. Our members can refresh and get access to an up-to-date AI stock analysis.

Sign up

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Eli Lilly and Company (LLY), currently trading at $788.2, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.